[EN] SMALL MOLECULE NEUTRAL SPHINGOMYELINASE 2 (NSMASE2) INHIBITORS<br/>[FR] INHIBITEURS DE LA SPHINGOMYÉLINASE NEUTRE DE TYPE 2 À PETITES MOLÉCULES (NSMASE2)
申请人:UNIV JOHNS HOPKINS
公开号:WO2020160148A1
公开(公告)日:2020-08-06
Small molecule inhibitors of neutral sphingomyelinase 2 (nSMase2) and their use for treating neurodegenerative diseases, such as, neurodegenerative diseases associated with high levels of ceramide, including, but not limited to Alzheimer's disease (AD), HIV-associated neurocognitive disorder (HAND), multiple sclerosis (MS), and amyotrophic lateral sclerosis (ALS), and, in other aspects, for treating cancer or HIV-1, are provided.
小分子抑制剂中和神经鞘磷脂酶2(nSMase2)及其用于治疗神经退行性疾病,如与高水平神经鞘磷脂有关的神经退行性疾病,包括但不限于阿尔茨海默病(AD)、艾滋病相关神经认知障碍(HAND)、多发性硬化(MS)和肌萎缩侧索硬化(ALS),以及在其他方面,用于治疗癌症或HIV-1。